98338329 - ORIONISBIO

Information

• Trademark
• 98338329

• Source

• Serial Number

  98338329

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 02, 2024
  a year ago

• Transaction Date

  October 29, 2024
  3 months ago

• Status Date

  October 29, 2024
  3 months ago

• Published for Opposition Date

  September 03, 2024
  4 months ago

• Location Date

  October 29, 2024
  3 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  DINALLO, KEVIN

• Attorney Docket Number

  114384-0005

  Attorney Name

  Rachelle A. Dubow, Esq.

  Law Office Assigned Location Code

  L70

• Owners

  • Orionis Biosciences Inc.

Case File Statements

• GS0051: Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; Pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
• GS0011: Diagnostic, biological and chemical reagents for scientific and research use; Pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases; Cytokines, namely, reagents for scientific and research use
• GS0421: Development of new technology for others in the field of biotechnology; Scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; Biotechnical research; Technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development of pharmaceuticals for others; Scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism

Case File Event Statements

• 1/2/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/16/2024 - 9 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/30/2024 - 6 months ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/30/2024 - 6 months ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/30/2024 - 6 months ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/30/2024 - 6 months ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 7/30/2024 - 6 months ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/30/2024 - 6 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/14/2024 - 5 months ago

  9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/3/2024 - 4 months ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/3/2024 - 4 months ago

  11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/29/2024 - 3 months ago

  12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM